A novel agent, para-toluenesulfonamide, for the management of malignant pleural effusions. Matching-adjusted indirect comparison of bireociclib plus fulvestrant versus abemaciclib plus fulvestrant as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results